Stay updated on OpACIN-neo Optimal Combo Trial

Sign up to get notified when there's something new on the OpACIN-neo Optimal Combo Trial page.
Latest website image capture
Clouds background image

Latest updates to the OpACIN-neo Optimal Combo Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study record is displayed with details about the OpACIN-neo melanoma trial, including its treatment arms, eligibility criteria, locations, and outcome measures.
    Difference
    73%
    Check dated 2026-11-07T13:07:43.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:34:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology across NIH content.
    Difference
    1%
    Check dated 2026-10-24T17:00:35.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the page displaying a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T16:49:34.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision indicator changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T17:11:23.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the expected content with an access-denied message.
    Difference
    21%
    Check dated 2026-09-19T20:33:43.000Z thumbnail image

Stay in the know with updates to OpACIN-neo Optimal Combo Trial

Enter your email address, and we'll notify you when there's something new on the OpACIN-neo Optimal Combo Trial page.